Підписатись
Daniel Wells
Daniel Wells
Epana Bio
Підтверджена електронна адреса в epana.bio
Назва
Посилання
Посилання
Рік
Clonal replacement of tumor-specific T cells following PD-1 blockade
KE Yost, AT Satpathy, DK Wells, Y Qi, C Wang, R Kageyama, ...
Nature medicine 25 (8), 1251-1259, 2019
12992019
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ...
Nature 551 (7681), 512-516, 2017
10972017
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
RN Amaria, SM Reddy, HA Tawbi, MA Davies, MI Ross, IC Glitza, ...
Nature medicine 24 (11), 1649-1654, 2018
7912018
Genetic mechanisms of immune evasion in colorectal cancer
CS Grasso*, M Giannakis*, DK Wells*, T Hamada, XJ Mu, M Quist, ...
Cancer discovery, 2018
4692018
Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction
DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ...
Cell 183 (3), 818-834. e13, 2020
4332020
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1c259T cells in Synovial Sarcoma
SP D'Angelo, L Melchiori, MS Merchant, DB Bernstein, J Glod, RN Kaplan, ...
Cancer discovery, CD-17-1417, 2018
4072018
Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen
SA Vardhana, MA Hwee, M Berisa, DK Wells, KE Yost, B King, M Smith, ...
Nature immunology 21 (9), 1022-1033, 2020
3622020
TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion
M Shakiba, P Zumbo, G Espinosa-Carrasco, L Menocal, F Dündar, ...
Journal of Experimental Medicine 219 (2), e20201966, 2021
1202021
Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L) 1 blockade in NSCLC
MD Hellmann, BY Nabet, H Rizvi, AA Chaudhuri, DK Wells, MPS Dunphy, ...
Clinical Cancer Research 26 (12), 2849-2858, 2020
1172020
Bystander T cells in cancer immunology and therapy
SL Meier, AT Satpathy, DK Wells
Nature Cancer 3 (2), 143-155, 2022
1072022
Control of stochastic and induced switching in biophysical networks
DK Wells, WL Kath, AE Motter
Physical Review X 5 (3), 031036, 2015
1072015
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
A Heczey, X Xu, AN Courtney, G Tian, GA Barragan, L Guo, CM Amador, ...
Nature Medicine 29 (6), 1379-1388, 2023
892023
Antitumor activity associated with prolonged persistence of adoptively transferred NY-ESO-1 (c259) T cells in synovial sarcoma. Cancer Discov. 2018; 8: 944–957. doi: 10.1158 …
SP D’angelo, L Melchiori, MS Merchant, D Bernstein, J Glod, R Kaplan, ...
CD-17-1417, 0
84
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
M Karasarides, AP Cogdill, PB Robbins, M Bowden, EM Burton, ...
Cancer Immunology Research, OF1-OF12, 2022
762022
Tumor characteristics associated with benefit from pembrolizumab in advanced non–small cell lung cancer
S Hu-Lieskovan, A Lisberg, JM Zaretsky, TR Grogan, H Rizvi, DK Wells, ...
Clinical cancer research 25 (16), 5061-5068, 2019
702019
Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade
JA Pai, MD Hellmann, JL Sauter, M Mattar, H Rizvi, HJ Woo, N Shah, ...
Cancer Cell 41 (4), 776-790. e7, 2023
622023
Prediction of SARS-CoV-2 epitopes across 9360 HLA class I alleles
KM Campbell, G Steiner, DK Wells, A Ribas, A Kalbasi
BioRxiv, 2020.03. 30.016931, 2020
512020
Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma
KM Campbell, M Amouzgar, SM Pfeiffer, TR Howes, E Medina, M Travers, ...
Cancer Cell 41 (4), 791-806. e4, 2023
452023
Spatial and functional heterogeneities shape collective behavior of tumor-immune networks
DK Wells, Y Chuang, LM Knapp, D Brockmann, WL Kath, JN Leonard
PLoS computational biology 11 (4), e1004181, 2015
362015
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational …
CF Friedman, C Spencer, CR Cabanski, KS Panageas, DK Wells, A Ribas, ...
Journal for immunotherapy of cancer 10 (1), e003853, 2022
352022
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20